Zobrazeno 1 - 10
of 369
pro vyhledávání: '"Matthew H.G. Katz"'
Autor:
Bradford J. Kim, MD, MHS, Elsa M. Arvide, MS PA-C, Cameron Gaskill, MD, MPH, Allison N. Martin, MD, MPH, Yoshikuni Kawaguchi, MD, PhD, Yi-Ju Chiang, MSPH, Whitney L. Dewhurst, MS NP-C, Teresa L. Phan, MSN, FNP-C, Hop S. Tran Cao, MD, Yun Shin Chun, MD, Matthew H.G. Katz, MD, Jean Nicolas Vauthey, MD, Ching-Wei D. Tzeng, MD, Timothy E. Newhook, MD
Publikováno v:
Surgery Open Science, Vol 9, Iss , Pp 109-116 (2022)
Background: The Kawaguchi–Gayet classification is a validated system to stratify open liver resections by complexity and postoperative complications. We hypothesized that Kawaguchi–Gayet classification could be used to create and implement risk-s
Externí odkaz:
https://doaj.org/article/9e57111c143c43f88b1146101398e8c3
Autor:
Timothy P. DiPeri, MD, Timothy E. Newhook, MD, Ryan W. Day, MD, Yi-Ju Chiang, MSPH, Whitney L. Dewhurst, MS, AGNP-C, Elsa M. Arvide, MS, PA-C, Morgan L. Bruno, MS, ACNP-BC, Christopher P. Scally, MD, MS, Christina L. Roland, MD, MS, Matthew H.G. Katz, MD, Jean-Nicolas Vauthey, MD, George J. Chang, MD, MS, Brian D. Badgwell, MD, MS, Nancy D. Perrier, MD, Elizabeth G. Grubbs, MD, Jeffrey E. Lee, MD, Ching-Wei D. Tzeng, MD, Brian K. Bednarski, MD, Iris B. Chen, MS, APRN, Ryan J. Comeaux, MS, PA-C, Dana M. Cox, MPAS, PA-C, Barry W. Feig, MD, Sarah B. Fisher, MD, Keith F. Fournier, MD, Semhar J. Ghebremichael, MD, Heather M. Gibson, MS, PA-C, Nicole C. Gourmelon, MS, PA-C, Paul H. Graham, MD, Shannon Hancher, MD, Kelly K. Hunt, MD, Naruhiko Ikoma, MD, MPH, Shanae L. Ivey MPAS, PA-C, Emily Z. Keung, MD, Celia R. Ledet, MD, Angela R. Limmer, MS, PA-C, Paul F. Mansfield, MD, Lauren K. Mayon, MS, PA-C, Craig A. Messick, MD, Keyuri U. Popat, MD, Nikita F. Rajkot MPAS, PA-C, Justine L. Robinson MPAS, PA-C, Kristen A. Robinson MPAS, PA-C, Miguel A. Rodriguez-Bigas, MD, David A. Santos, MD, MS, John M. Skibber, MD, B. Bryce Speer, DO, Jose Soliz, MD, Matthew M. Tillman, MD, Keila E. Torres, MD, Antoinette van Meter, MD, Marla E. Weldon, MS, PA-C, Uduak Ursula Williams, MD, Y. Nancy You, MD, MHSc
Publikováno v:
Surgery Open Science, Vol 9, Iss , Pp 51-57 (2022)
Background: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care. Methods: Faculty-based surgical teams
Externí odkaz:
https://doaj.org/article/eb76d169a7434c548f83e4fa72a03946
Autor:
Alexander F. Bagley, Ethan B. Ludmir, Anirban Maitra, Bruce D. Minsky, Grace Li Smith, Prajnan Das, Albert C. Koong, Emma B. Holliday, Cullen M. Taniguchi, Matthew H.G. Katz, Eric P. Tamm, Robert A. Wolff, Michael J. Overman, Shivani Patel, Michael P. Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Manoop S. Bhutani, Eugene J. Koay
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 66-69 (2022)
Background and purpose: Pancreatic ductal adenocarcinoma (PDAC) remains one of the leading causes of cancer-related deaths in the world. For patients with PDAC who are not eligible for surgery, radiation therapy improves local disease control, yet sa
Externí odkaz:
https://doaj.org/article/928b9cb96de949b2aa06a4d2d39c4f62
Autor:
Ya’an Kang, Jenying Deng, Jianhua Ling, Xinqun Li, Yi-Ju Chiang, Eugene J. Koay, Huamin Wang, Jared K. Burks, Paul J. Chiao, Mark W. Hurd, Manoop S. Bhutani, Jeffrey H. Lee, Brian R. Weston, Anirban Maitra, Naruhiko Ikoma, Ching-Wei D. Tzeng, Jeffrey E. Lee, Ronald A. DePinho, Robert A. Wolff, Shubham Pant, Florencia McAllister, Matthew H.G. Katz, Jason B. Fleming, Michael P. Kim
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 24 (2022)
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, with unpredictable responses to chemotherapy. Approaches to assay patient tumors before treatment and identify effective treatment regimens based on tumor sens
Externí odkaz:
https://doaj.org/article/79511496d0394ed69402ac29b6420cc6
Autor:
Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind M. Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H.G. Katz, Shubham Pant, Ching‐Wei D. Tzeng, Florencia McAllister
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5041-5050 (2021)
Abstract Recent studies defined a potentially important role of the microbiome in modulating pancreatic ductal adenocarcinoma (PDAC) and responses to therapies. We hypothesized that antibiotic usage may predict outcomes in patients with PDAC. We retr
Externí odkaz:
https://doaj.org/article/0a9f7dec3b6a427caf5cf0242b007a10
Autor:
Yihui Chen, Michela Capello, Mayrim V. Rios Perez, Jody V. Vykoukal, David Roife, Ya'an Kang, Laura R. Prakash, Hiroyuki Katayama, Ehsan Irajizad, Alia Fleury, Sammy Ferri-Borgogno, Dodge L. Baluya, Jennifer B. Dennison, Kim-Anh Do, Oliver Fiehn, Anirban Maitra, Huamin Wang, Paul J. Chiao, Matthew H.G. Katz, Jason B. Fleming, Samir M. Hanash, Johannes F. Fahrmann
Publikováno v:
Molecular Metabolism, Vol 56, Iss , Pp 101426- (2022)
Objective: Intra-tumoral expression of the serine hydrolase carboxylesterase 2 (CES2) contributes to the activation of the pro-drug irinotecan in pancreatic ductal adenocarcinoma (PDAC). Given other potential roles of CES2, we assessed its regulation
Externí odkaz:
https://doaj.org/article/f9a47ca82b9a4a3aa384f17421d279f9
Autor:
Manoop S. Bhutani, MD, FASGE, Irina M. Cazacu, MD, Alexandra A. Luzuriaga Chavez, MD, Ben S. Singh, BA, Franklin C.L. Wong, MD, William D. Erwin, MS, Eric P. Tamm, MD, Geena G. Mathew, MS, Dao B. Le, PharmD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD, Bruce D. Minsky, MD, Shubham Pant, MD, Ching-Wei D. Tzeng, MD, Albert C. Koong, MD, PhD, Gauri R. Varadhachary, MD, Matthew H.G. Katz, MD, Robert A. Wolff, MD, David R. Fogelman, MD, Joseph M. Herman, MD
Publikováno v:
VideoGIE, Vol 4, Iss 5, Pp 223-225 (2019)
Externí odkaz:
https://doaj.org/article/42ed4fd9af0f498d9b2f592a389b6be2
Autor:
Masanori Oshi, Yoshihisa Tokumaru, Ankit Patel, Li Yan, Ryusei Matsuyama, Itaru Endo, Matthew H.G. Katz, Kazuaki Takabe
Publikováno v:
Cancers, Vol 12, Iss 12, p 3635 (2020)
Pathologically complete (R0) resection is essential for prolonged survival in pancreatic cancer. Survival depends not only on surgical technique, but also on cancer biology. A biomarker to predict survival is a critical need in pancreatic treatment.
Externí odkaz:
https://doaj.org/article/3917805957344888bdc4cc54123cf47b
Autor:
Hideo Takahashi, Eriko Katsuta, Li Yan, Yoshihisa Tokumaru, Matthew H.G. Katz, Kazuaki Takabe
Publikováno v:
Cancers, Vol 12, Iss 8, p 2033 (2020)
Lymphovascular invasion (LVI) is an aggressive pathologic feature and considered a risk factor for distant metastasis. We hypothesized that pancreatic ductal adenocarcinomas (PDACs) with LVI are associated with shorter survival, as well as aggressive
Externí odkaz:
https://doaj.org/article/fc8aa9201b6c48e09c3f15451daae0ae
Publikováno v:
Surgical Oncology Clinics of North America. 32:327-342